Cited by 477

The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

Verma, Atul, Cairns, John A., Mitchell, L. Brent, Macle, Laurent, Stiell, Ian G., Gladstone, David, McMurtry, Michael Sean, Connolly, Stuart, Cox, Jafna L., Dorian, Paul, Ivers, Noah, Leblanc, Kori, Nattel, Stanley, Healey, Jeff S.·2014·Canadian Journal of Cardiology

DOI 10.1016/j.cjca.2014.08.001

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cjca.2014.08.001

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Untitled work
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Edoxaban versus warfarin in patients with atrial fibrillation
Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Apixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
Holmes, D. R., Reddy, V. Y., Turi, Z. G., Doshi, S. K., Sievert, H., Buchbinder, M., Mullin, C. M., & Sick, P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61343-x · Cited by 2,240
Cryptogenic stroke and underlying atrial fibrillation
Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161
Subclinical atrial fibrillation and the risk of stroke
Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000040 · Cited by 2,056
Embolic strokes of undetermined source: the case for a new clinical construct
Hart, R. G., Diener, H.-C., Coutts, S. B., Easton, J. D., Granger, C. B., O'Donnell, M. J., Sacco, R. L., & Connolly, S. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70310-7 · Cited by 1,681
Self-citation
Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Spyropoulos, A. C., Spencer, F. A., Mayr, M., Jaffer, A. K., Eckman, M. H., Dunn, A. S., & Kunz, R. (2012) · Chest · doi:10.1378/chest.11-2298 · Cited by 1,641
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
Olesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., Selmer, C., Ahlehoff, O., Olsen, A.-M. S., Gislason, G. H., et al. (2011) · BMJ · doi:10.1136/bmj.d124 · Cited by 1,428
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation: A Randomized Controlled Trial
Wilber, D. J., Pappone, C., Neuzil, P., De Paola, A., Marchlinski, F., Natale, A., Macle, L., Daoud, E. G., Calkins, H., Hall, B., et al. (2010) · JAMA · doi:10.1001/jama.2009.2029 · Cited by 1,170
Self-citation
Antithrombotic Therapy for Atrial Fibrillation
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · Chest · doi:10.1378/chest.11-2304 · Cited by 918
Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation
Packer, D. L., Kowal, R. C., Wheelan, K. R., Irwin, J. M., Champagne, J., Guerra, P. G., Dubuc, M., Reddy, V., Nelson, L., Holcomb, R. G., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.064 · Cited by 899
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study
Jaïs, P., Cauchemez, B., Macle, L., Daoud, E., Khairy, P., Subbiah, R., Hocini, M., Extramiana, F., Sacher, F., Bordachar, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.772582 · Cited by 891
Self-citation
The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study
Glotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Ezekowitz, M. D., Hilker, C., Miller, C., Qi, D., & Ziegler, P. D. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.849638 · Cited by 879
Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses
Calkins, H., Reynolds, M. R., Spector, P., Sondhi, M., Xu, Y., Martin, A., Williams, C. J., & Sledge, I. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.824789 · Cited by 847
Management of Anticoagulation before and after Elective Surgery
Kearon, C., & Hirsh, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705223362107 · Cited by 812
Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis
Ganesan, A. N., Shipp, N. J., Brooks, A. G., Kuklik, P., Lau, D. H., Lim, H. S., Sullivan, T., Roberts‐Thomson, K. C., & Sanders, P. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.004549 · Cited by 800
Selecting Patients With Atrial Fibrillation for Anticoagulation: Stroke Risk Stratification in Patients Taking Aspirin
Gage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Catheter Ablation for Atrial Fibrillation
Weerasooriya, R., Khairy, P., Litalien, J., Macle, L., Hocini, M., Sacher, F., Lellouche, N., Knecht, S., Wright, M., Nault, I., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.061 · Cited by 737
Self-citation
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation
Cosedis Nielsen, J., Johannessen, A., Raatikainen, P., Hindricks, G., Walfridsson, H., Kongstad, O., Pehrson, S., Englund, A., Hartikainen, J., Mortensen, L. S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113566 · Cited by 720
Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis
Sposato, L. A., Cipriano, L. E., Saposnik, G., Vargas, E. R., Riccio, P. M., & Hachinski, V. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70027-x · Cited by 694
Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial
Reddy, V. Y., Doshi, S. K., Sievert, H., Buchbinder, M., Neuzil, P., Huber, K., Halperin, J. L., & Holmes, D. (2013) · Circulation · doi:10.1161/circulationaha.112.114389 · Cited by 677
Temporal relationship between subclinical atrial fibrillation and embolic events
Brambatti, M., Connolly, S. J., Gold, M. R., Morillo, C. A., Capucci, A., Muto, C., Lau, C. P., Van Gelder, I. C., Hohnloser, S. H., Carlson, M., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007825 · Cited by 676
Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2): A Randomized Trial
Morillo, C. A., Verma, A., Connolly, S. J., Kuck, K. H., Nair, G. M., Champagne, J., Sterns, L. D., Beresh, H., Healey, J. S., Natale, A., et al. (2014) · JAMA · doi:10.1001/jama.2014.467 · Cited by 667
Self-citation
In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in the United States Between 2000 and 2010: Analysis of 93 801 Procedures
Deshmukh, A., Patel, N. J., Pant, S., Shah, N., Chothani, A., Mehta, K., Grover, P., Singh, V., Vallurupalli, S., Savani, G. T., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003862 · Cited by 581
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
Birnie, D. H., Healey, J. S., Wells, G. A., Verma, A., Tang, A. S., Krahn, A. D., Simpson, C. S., Ayala-Paredes, F., Coutu, B., Leiria, T. L. L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302946 · Cited by 579
Self-citation
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial
Healey, J. S., Eikelboom, J., Douketis, J., Wallentin, L., Oldgren, J., Yang, S., Themeles, E., Heidbuchel, H., Avezum, A., Reilly, P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.090464 · Cited by 541
Self-citation
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)†
Stabile, G., Bertaglia, E., Senatore, G., De Simone, A., Zoppo, F., Donnici, G., Turco, P., Pascotto, P., Fazzari, M., & Vitale, D. F. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi583 · Cited by 503
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) Study Cohorts
Piccini, J. P., Stevens, S. R., Chang, Y., Singer, D. E., Lokhnygina, Y., Go, A. S., Patel, M. R., Mahaffey, K. W., Halperin, J. L., Breithardt, G., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.107128 · Cited by 502
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
Skanes, A. C., Healey, J. S., Cairns, J. A., Dorian, P., Gillis, A. M., McMurtry, M. S., Mitchell, L. B., Verma, A., & Nattel, S. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.01.021 · Cited by 494
Self-citation
Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management: Results From the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) Randomized Trial
Di Biase, L., Burkhardt, J. D., Santangeli, P., Mohanty, P., Sanchez, J. E., Horton, R., Gallinghouse, G. J., Themistoclakis, S., Rossillo, A., Lakkireddy, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006426 · Cited by 485
Periprocedural Heparin Bridging in Patients Receiving Vitamin K Antagonists: Systematic Review and Meta-Analysis of Bleeding and Thromboembolic Rates
Siegal, D., Yudin, J., Kaatz, S., Douketis, J. D., Lim, W., & Spyropoulos, A. C. (2012) · Circulation · doi:10.1161/circulationaha.112.105221 · Cited by 440
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor
Kubitza, D., Becka, M., Mueck, W., Halabi, A., Maatouk, H., Klause, N., Lufft, V., Wand, D. D., Philipp, T., & Bruck, H. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03753.x · Cited by 432
Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry
Beyer-Westendorf, J., Gelbricht, V., Forster, K., Ebertz, F., Kohler, C., Werth, S., Kuhlisch, E., Stange, T., Thieme, C., Daschkow, K., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht557 · Cited by 383
Detection of Atrial Fibrillation After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Kishore, A., Vail, A., Majid, A., Dawson, J., Lees, K. R., Tyrrell, P. J., & Smith, C. J. (2014) · Stroke · doi:10.1161/strokeaha.113.003433 · Cited by 374
Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published studies
Andrade, J. G., Khairy, P., Guerra, P. G., Deyell, M. W., Rivard, L., Macle, L., Thibault, B., Talajic, M., Roy, D., & Dubuc, M. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.03.050 · Cited by 360
Self-citation
Incidence of Asymptomatic Intracranial Embolic Events After Pulmonary Vein Isolation
Herrera Siklódy, C., Deneke, T., Hocini, M., Lehrmann, H., Shin, D.-I., Miyazaki, S., Henschke, S., Fluegel, P., Schiebeling-Römer, J., Bansmann, P. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.010 · Cited by 356
Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vanga, S. R., Santangeli, P., Swarup, V., Pimentel, R., Mansour, M. C., D'Avila, A., Sanchez, J. E., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.12.014 · Cited by 356
Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS
Daoud, E. G., Glotzer, T. V., Wyse, D. G., Ezekowitz, M. D., Hilker, C., Koehler, J., & Ziegler, P. D. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.04.022 · Cited by 326
Complications of Catheter Ablation of Atrial Fibrillation: A Systematic Review
Gupta, A., Perera, T., Ganesan, A., Sullivan, T., Lau, D. H., Roberts-Thomson, K. C., Brooks, A. G., & Sanders, P. (2013) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000768 · Cited by 317
Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation (DISCERN AF): A Prospective, Multicenter Study
Verma, A., Champagne, J., Sapp, J., Essebag, V., Novak, P., Skanes, A., Morillo, C. A., Khaykin, Y., & Birnie, D. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1561 · Cited by 315
Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation: The Impact of Periprocedural Therapeutic International Normalized Ratio
Di Biase, L., Burkhardt, J. D., Mohanty, P., Sanchez, J., Horton, R., Gallinghouse, G. J., Lakkireddy, D., Verma, A., Khaykin, Y., Hongo, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.921320 · Cited by 294
Self-citation
Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized, Controlled Trials
Piccini, J. P., Lopes, R. D., Kong, M. H., Hasselblad, V., Jackson, K., & Al-Khatib, S. M. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.856633 · Cited by 290
Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation
Lip, G. Y. H., Larsen, T. B., Skjøth, F., & Rasmussen, L. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.019 · Cited by 288
Incidence of Silent Cerebral Thromboembolic Lesions After Atrial Fibrillation Ablation May Change According to Technology Used: Comparison of Irrigated Radiofrequency, Multipolar Nonirrigated Catheter and Cryoballoon
GAITA, F., LECLERCQ, J. F., SCHUMACHER, B., SCAGLIONE, M., TOSO, E., HALIMI, F., SCHADE, A., FROEHNER, S., ZIEGLER, V., SERGI, D., et al. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02050.x · Cited by 286
Procedural Complications, Rehospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrillation
Shah, R. U., Freeman, J. V., Shilane, D., Wang, P. J., Go, A. S., & Hlatky, M. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.068 · Cited by 281
Increased mortality among patients taking digoxin—analysis from the AFFIRM study
Whitbeck, M. G., Charnigo, R. J., Khairy, P., Ziada, K., Bailey, A. L., Zegarra, M. M., Shah, J., Morales, G., Macaulay, T., Sorrell, V. L., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs348 · Cited by 279
Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin
Majeed, A., Hwang, H.-G., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Wallentin, L., Brueckmann, M., Fraessdorf, M., Yusuf, S., & Schulman, S. (2013) · Circulation · doi:10.1161/circulationaha.113.002332 · Cited by 277
Self-citation
Prolonged Rhythm Monitoring for the Detection of Occult Paroxysmal Atrial Fibrillation in Ischemic Stroke of Unknown Cause
Seet, R. C. S., Friedman, P. A., & Rabinstein, A. A. (2011) · Circulation · doi:10.1161/circulationaha.111.029801 · Cited by 276
Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation
Airaksinen, K. E. J., Grönberg, T., Nuotio, I., Nikkinen, M., Ylitalo, A., Biancari, F., & Hartikainen, J. E. K. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.089 · Cited by 258
Long-Term Outcome After Successful Catheter Ablation of Atrial Fibrillation
Tzou, W. S., Marchlinski, F. E., Zado, E. S., Lin, D., Dixit, S., Callans, D. J., Cooper, J. M., Bala, R., Garcia, F., Hutchinson, M. D., et al. (2010) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.923771 · Cited by 237
Warfarin in atrial fibrillation patients with moderate chronic kidney disease
Hart, R. G., Pearce, L. A., Asinger, R. W., & Herzog, C. A. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02400311 · Cited by 204
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial
Gheorghiade, M., Fonarow, G. C., van Veldhuisen, D. J., Cleland, J. G. F., Butler, J., Epstein, A. E., Patel, K., Aban, I. B., Aronow, W. S., Anker, S. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht120 · Cited by 192
Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death
Hunter, R. J., McCready, J., Diab, I., Page, S. P., Finlay, M., Richmond, L., French, A., Earley, M. J., Sporton, S., Jones, M., et al. (2012) · Heart · doi:10.1136/heartjnl-2011-300720 · Cited by 183
Complications arising from catheter ablation of atrial fibrillation: Temporal trends and predictors
Hoyt, H., Bhonsale, A., Chilukuri, K., Alhumaid, F., Needleman, M., Edwards, D., Govil, A., Nazarian, S., Cheng, A., Henrikson, C. A., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.07.025 · Cited by 181
Frequent Atrial Premature Beats Predict Paroxysmal Atrial Fibrillation in Stroke Patients: An Opportunity for a New Diagnostic Strategy
Wallmann, D., Tüller, D., Wustmann, K., Meier, P., Isenegger, J., Arnold, M., Mattle, H. P., & Delacrétaz, E. (2007) · Stroke · doi:10.1161/strokeaha.107.485110 · Cited by 177
Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
Lakkireddy, D., Reddy, Y. M., Di Biase, L., Vallakati, A., Mansour, M. C., Santangeli, P., Gangireddy, S., Swarup, V., Chalhoub, F., Atkins, D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.039 · Cited by 177
Self-citation
Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial
Kirchhof, P., Andresen, D., Bosch, R., Borggrefe, M., Meinertz, T., Parade, U., Ravens, U., Samol, A., Steinbeck, G., Treszl, A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60570-4 · Cited by 176
Atrial Fibrillation in Ischemic Stroke: Predicting Response to Thrombolysis and Clinical Outcomes
Saposnik, G., Gladstone, D., Raptis, R., Zhou, L., & Hart, R. G. (2013) · Stroke · doi:10.1161/strokeaha.112.676551 · Cited by 174
Self-citation
Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion
Gallagher, M. M., Hennessy, B. J., Edvardsson, N., Hart, C. M., Shannon, M. S., Obel, O. A., Al-Saady, N. M., & Camm, A. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02052-1 · Cited by 174
Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00018 · Cited by 173
Ablation of Atrial Fibrillation Under Therapeutic Warfarin Reduces Periprocedural Complications: Evidence From a Meta-Analysis
Santangeli, P., Di Biase, L., Horton, R., Burkhardt, J. D., Sanchez, J., Al-Ahmad, A., Hongo, R., Beheiry, S., Bai, R., Mohanty, P., et al. (2012) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.964916 · Cited by 173
Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
Bassiouny, M., Saliba, W., Rickard, J., Shao, M., Sey, A., Diab, M., Martin, D. O., Hussein, A., Khoury, M., Abi-Saleh, B., et al. (2013) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000320 · Cited by 164
The Efficacy of Aspirin in Patients With Atrial Fibrillation: Analysis of Pooled Data From 3 Randomized Trials
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440320143013 · Cited by 161
An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation
Ansell, J., & Mantha, S. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-02-0093 · Cited by 154
Long-Term Outcomes After Cryoballoon Pulmonary Vein Isolation
Vogt, J., Heintze, J., Gutleben, K. J., Muntean, B. G., Horstkotte, D., & Nölker, G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.033 · Cited by 152
Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score
Bunch, T. J., May, H. T., Bair, T. L., Weiss, J. P., Crandall, B. G., Osborn, J. S., Mallender, C. D., Anderson, J. L., Muhlestein, B., LAPPE, D. L., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.07.002 · Cited by 147
Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
Kim, J. S., She, F., Jongnarangsin, K., Chugh, A., Latchamsetty, R., Ghanbari, H., Crawford, T. C., Suwanagool, A., Sinno, M., Carrigan, T., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.12.011 · Cited by 145
Association of atrial fibrillation with mortality and disability after ischemic stroke
McGrath, E. R., Kapral, M. K., Fang, J., Eikelboom, J. W., O’Conghaile, A., Canavan, M. D., O'Donnell, M. J., & On behalf of the Investigators of the Ontario Stroke Registry (2013) · Neurology · doi:10.1212/wnl.0b013e3182a2cc15 · Cited by 143
Evaluation and Reduction of Asymptomatic Cerebral Embolism in Ablation of Atrial Fibrillation, But High Prevalence of Chronic Silent Infarction
Verma, A., Debruyne, P., Nardi, S., Deneke, T., Greef, Y. D., Spitzer, S. G., Balzer, J. O., & Boersma, L. V. A. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000612 · Cited by 137
Self-citation
Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation [RETIRED]
Culebras, A., Messe, S. R., Chaturvedi, S., Kase, C. S., & Gronseth, G. (2014) · Neurology · doi:10.1212/wnl.0000000000000145 · Cited by 134
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
Aguilar, M. I., & Hart, R. G. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001925.pub2 · Cited by 128
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department
Stiell, I. G., & Macle, L. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.014 · Cited by 127
Self-citation
Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German Ablation Registry
SCHMIDT, M., DORWARTH, U., ANDRESEN, D., BRACHMANN, J., KUCK, K., KUNISS, M., LEWALTER, T., SPITZER, S., WILLEMS, S., SENGES, J., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12267 · Cited by 126
Noninvasive Cardiac Event Monitoring to Detect Atrial Fibrillation After Ischemic Stroke: A Randomized, Controlled Trial
Higgins, P., Macfarlane, P. W., Dawson, J., McInnes, G. T., Langhorne, P., & Lees, K. R. (2013) · Stroke · doi:10.1161/strokeaha.113.001927 · Cited by 126
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management
Gillis, A. M., Verma, A., Talajic, M. R., Nattel, S., & Dorian, P. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.001 · Cited by 124
Self-citation
Cardioversion of Paroxysmal Atrial Fibrillation in the Emergency Department
Michael, J. A., Stiell, I. G., AGARWAL, S., & Mandavia, D. P. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70300-8 · Cited by 118
Self-citation
Association of the Ottawa Aggressive Protocol with rapid discharge of emergency department patients with recent-onset atrial fibrillation or flutter
Stiell, I. G., Clement, C. M., Perry, J. J., Vaillancourt, C., Symington, C., Dickinson, G. E., Birnie, D. H., & Green, M. S. (2010) · Canadian Journal of Emergency Medicine · doi:10.1017/s1481803500012227 · Cited by 116
Self-citation
Renal Impairment and Ischemic Stroke Risk Assessment in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.035 · Cited by 116
Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
Roldán, V., Marín, F. R., Manzano‐Fernández, S., Fernández, H., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0054 · Cited by 111
Health Outcomes With Catheter Ablation or Antiarrhythmic Drug Therapy in Atrial Fibrillation
Reynolds, M. R., Gunnarsson, C., Hunter, T. D., Ladapo, J. A., March, J. L., Zhang, M., & Hao, S. C. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.963108 · Cited by 109
Electrical cardioversion of emergency department patients with atrial fibrillation
Burton, J. H., Vinson, D. R., Drummond, K., Strout, T. D., Thode, H. C., & McInturff, J. J. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.02.016 · Cited by 93
Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral Anticoagulation
Healey, J. S., Martin, J. L., Duncan, A., Connolly, S. J., Ha, A. H., Morillo, C. A., Nair, G. M., Eikelboom, J. W., Divakaramenon, S., & Dokainish, H. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.08.019 · Cited by 90
Self-citation
A Prospective Study of Estimated Glomerular Filtration Rate and Outcomes in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-2103 · Cited by 89
Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial
Apostolakis, S. Z., Guo, Y., Lane, D. A., Buller, H. R., & Lip, G. Y. H. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht328 · Cited by 87
Supraventricular Premature Beats and Short Atrial Runs Predict Atrial Fibrillation in Continuously Monitored Patients With Cryptogenic Stroke
Kochhäuser, S., Dechering, D. G., Dittrich, R., Reinke, F., Ritter, M., Ramtin, S., Duning, T., Frommeyer, G., & Eckardt, L. (2014) · Stroke · doi:10.1161/strokeaha.113.003788 · Cited by 86
Phased RF ablation in persistent atrial fibrillation
Hummel, J. D., Michaud, G. F., HOYT, R. H., DeLurgio, D. B., Rasekh, A., Kusumoto, F. M., GIUDICI, M. C., Dan, D., Tschopp, D. R., Calkins, H. G., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.11.009 · Cited by 80
Safety and efficacy of dabigatran versus warfarin in patients undergoing catheter ablation of atrial fibrillation: a systematic review and meta-analysis
Providencia, R. A., Albenque, J., Combes, S., Bouzeman, A., Casteigt, B. J., Combes, N., Narayanan, K., Marijon, É., & Bovéda, S. (2013) · Heart · doi:10.1136/heartjnl-2013-304386 · Cited by 78
An International View of How Recent‐onset Atrial Fibrillation Is Treated in the Emergency Department
Rogenstein, C., Kelly, A., Mason, S. M., Schneider, S. M., Lang, E., Clement, C. M., & Stiell, I. G. (2012) · Academic Emergency Medicine · doi:10.1111/acem.12016 · Cited by 77
Self-citation
Thirty‐day Outcomes of Emergency Department Patients Undergoing Electrical Cardioversion for Atrial Fibrillation or Flutter
Scheuermeyer, F. X., Grafstein, E., Stenstrom, R., Innes, G. D., Poureslami, I. M., & Sighary, M. (2010) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2010.00697.x · Cited by 65
Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study
Wachter, R., Weber-Krüger, M., Seegers, J., Edelmann, F., Wohlfahrt, J., Wasser, K., Gelbrich, G., Hasenfuss, G. P., Stahrenberg, R., Liman, J., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-6935-x · Cited by 51
Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation—The potential role beyond the CHA2DS2-VASc score
Chao, T., Tsao, H.-M., Kibos, A., Lin, Y., Lin, W., Chang, S., Lo, L., Hu, Y., Tuan, T., Suenari, K., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.06.039 · Cited by 45
Excessive Supraventricular Ectopic Activity Is Indicative of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia
Weber-Krüger, M., Gröschel, K., Mende, M., Seegers, J., Lahno, R., Haase, B., Niehaus, C., Edelmann, F., Hasenfuss, G. P., Wachter, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067602 · Cited by 43
Managing Recent-Onset Atrial Fibrillation in the Emergency Department
Stiell, I. G., & Birnie, D. H. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2010.04.006 · Cited by 25
Self-citation
2010 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Training Standards and Maintenance of Competency in Adult Clinical Cardiac Electrophysiology
Green, M. S., Guerra, P. G., & Krahn, A. D. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.03.002 · Cited by 21
CANadian Network and Centre for Trials INternationally (CANNeCTIN): A national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus
Cairns, J. A., Yusuf, S., Cook, R. J., Cox, J. L., Dagenais, G. R., Devereaux, P. J., McAlister, F. A., & McCready, T. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70408-6 · Cited by 12
Self-citation
Use of Apixaban and Warfarin in Patients Undergoing Invasive Procedures: Insights From Aristotle
Lopes, R. D., Garcia, D. A., WOJDYLA, D. M., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.07.375 · Cited by 4

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000311 · Cited by 595
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.856 · Cited by 439
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
Cappato, R., Marchlinski, F. E., Hohnloser, S. H., Naccarelli, G. V., Xiang, J., Wilber, D. J., Ma, C.-S., Hess, S., Wells, D. S., Juang, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv177 · Cited by 422
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis
Proietti, M., Romanazzi, I., Romiti, G. F., Farcomeni, A., & Lip, G. Y. H. (2018) · Stroke · doi:10.1161/strokeaha.117.018395 · Cited by 126
Clinical Use of Digitalis: A State of the Art Review
Whayne, T. F. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0292-1 · Cited by 99

See all 477

Authors: Verma, A., Cairns, J. A., Mitchell, L. B., Macle, L., Stiell, I. G., Gladstone, D., McMurtry, M. S., Connolly, S., Cox, J. L., Dorian, P., Ivers, N., Leblanc, K., Nattel, S., & Healey, J. S.
Venue: Canadian Journal of Cardiology
Publisher: Elsevier BV
Published: 2014-10
Volume: 30
Issue: 10
Pages: 1114-1130
ISSN: 0828-282X (ISSN-L)
DOI: 10.1016/j.cjca.2014.08.001
OpenAlex: W2013311776
Cited by: 477
References: 107
FWCI: 52.23
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources